MCAG
Mountain Crest Acquisition Corp. VPrice
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- X Apr 30 Short interest falls 72.2% to 75
Signal stack
Where each data set points today.
- Short sellersSTEADY
Short interest 0.0% to 75 shares.
- TrendRANGE
0% above its 50-day average. New closing high $13.27 on Oct 26.
Who's buying
13F| Top holder | Shares | Value |
|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 17,855 | $198.2K |
Quarterly 13F filings are due 45 days after each quarter ends.
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Short side
FINRA· Jun 15, 2026SecBot reports
2 filings · 0 bullish · 0 bearish · 2 neutral- NEUTRAL DEFM14AOct 20, 2026
Mountain Crest Acquisition Corp. V (MCAG) is seeking stockholder approval for its business…
The deal is virtually assured to pass given Sponsor control (~70.5%). Key risk is the earnout threshold ($42.7M revenue in 2026) given CubeBio has zero revenue and a delayed commercialization…
- NEUTRAL DEF 14AOct 14, 2026
Mountain Crest Acquisition Corp. V is soliciting stockholder approval to extend its business…
The extension is virtually guaranteed given insider control, but the key variable is the redemption rate at the November 10 special meeting and the subsequent Business Combination vote on November…
All MCAG filing & press-release reports (2)
- DEFM14A reportOct 20, 2026
- DEF 14A reportOct 14, 2026